Literatur zum Artikel: Bingel U et al.: Migräne und idiopathischer Kopfschmerzsyndrome

• Literatur

• 1 American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 1994; 93: 137-150.
• 2 Acs N. et al. A possible dose-dependent teratogenic effect of ergotamine. Reprod Toxicol 2006; 22: 551-555.
• 3 Adeney KL. et al. Risk of preeclampsia in relation to maternal history of migraine headaches. J Matern Fetal Neonatal Med 2005; 18: 167-172.
• 4 Andrasik F. Behavioral treatment approaches to chronic headache. Neurol Sci 2003; 24 Suppl 2: S80-85.
• 5 Aouad MT. et al. Does pregnancy protect against intrathecal lidocaine-induced transient neurologic symptoms?. Anesth Analg 2001; 92: 401-404.
• 6 Bahra A, May A, Goadsby PJ. Cluster headache: a prospective clinical study with diagnostic implications. Neurology 2002; 58: 354-361.
• 7 Banhidy F. et al. Maternal severe migraine and risk of congenital limb deficiencies. Birth Defects Res A Clin Mol Teratol 2006; 76: 592-601.
• 8 Banhidy F. et al. Pregnancy complications and delivery outcomes in pregnant women with severe migraine. Eur J Obstet Gynecol Reprod Biol. 2006
• 9 Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. Philadelphia, Lippincott: Williams & Wilkins; 2005
• 10 Butters L. et al. Atenolol in essential hypertension during pregnancy. Bmj 1990; 301: 587-589.
• 11 Campbell JK. et al. Evidenced-based guidelines for migraine headache: behavioral and physical treatments: US Headache Consortium. 2004
• 12 Campbell OM, Gray RH. Characteristics and determinants of postpartum ovarian function in women in the US. Am J Obstet Gynecol 1993; 169: 55-60.
• 13 Chancellor AM. et al. Migraine occurring for the first time in pregnancy. Headache 1990; 30: 224-7.
• 14 Chen TC, Leviton A. Headache recurrence in pregnant women with migraine. Headache 1994; 34: 107-110.
• 15 Cheschier N. ACOG practice bulletin. Neural tube defects. Number 44, July 2003. (Replaces committee opinion number 252, March 2001). Int J Gynaecol Obstet 2003; 83: 123-133.
• 16 Cohen LS. et al. A reevaluation of risk of in utero exposure to lithium. Jama 1994; 271: 146-150.
• 17 Cupini L. et al. Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia 1995; 15: 140-144.
• 18 Dodick DW. et al. Cluster headache. Cephalalgia 2000; 20: 787-803.
• 19 Einarson A. et al. Treatment of nausea and vomiting in pregnancy: an updated algorithm. Can Fam Physician 2007; 53: 2109-2111.
• 20 Ekbom K, Waldenlind E. Cluster headache in women: evidence of hypofertility Headaches in relation to menstruation and pregnancy. Cephalalgia 1981; 01: 167-174.
• 21 Ellis GL. et al. The efficacy of metoclopramide in the treatment of migraine headache. Ann Emerg Med 1993; 22: 191-195.
• 22 Ericson A, Kallen BA. Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol 2001; 15: 371-375.
• 23 Ertresvag JM. et al. Headache and transient focal neurological symptoms during pregnancy, a prospective cohort. Acta Neurol Scand 2005; 111: 233-237.
• 24 Fiore M. et al. Exposure to rizatriptan during pregnancy: post-marketing experience up to 30 June 2004. Cephalalgia 2005; 25: 685-688.
• 25 Fox AW. et al. Evidence-based assessment of pregnancy outcome after sumatriptan exposure. Headache 2002; 42: 8-15.
• 26 Giuliani M. et al. Could local anesthesia while breast-feeding be harmful to infants?. J Pediatr Gastroenterol Nutr 2001; 32: 142-144.
• 27 Gobel H. et al. [Effectiveness of Oleum menthae piperitae and paracetamol in therapy of headache of the tension type]. Nervenarzt 1996; 67: 672-681.
• 28 Granella F. et al. Migraine with aura and reproductive life events: a case control study. Cephalalgia 2000; 20: 701-707.
• 29 Guay J. et al. Lidocaine hydrocarbonate and lidocaine hydrochloride for cesarean section: transplacental passage and neonatal effects. Acta Anaesthesiol Scand 1992; 36: 722-727.
• 30 Gur C. et al. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol 2004; 18: 93-101.
• 31 Hecht A. Drug safety labeling for doctors. FDA Consum 1979; 13: 12-13.
• 32 James AH. et al. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005; 106: 509-516.
• 33 Kallen B, Lygner PE. Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. Headache 2001; 41: 351-356.
• 34 Kristensen JH. et al. Transfer of the antidepressant mirtazapine into breast milk. Br J Clin Pharmacol 2007; 63: 322-327.
• 35 MacGregor EA. et al. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 2006; 67: 2154-2158.
• 36 Maggioni F. et al. Headache during pregnancy. Cephalalgia 1997; 17: 765-769.
• 37 Mandel S. Hemiplegic migraine in pregnancy. Headache 1988; 28: 414-416.
• 38 Manzoni GC. et al. Cluster headache in women: clinical findings and relationship with reproductive life. Cephalalgia 1988; 08: 37-44.
• 39 Marcoux S. et al. History of migraine and risk of pregnancy-induced hypertension. Epidemiology 1992; 03: 53-56.
• 40 Marcus DA, Scharff L, Turk D. Longitudinal prospective study of headache during pregnancy and postpartum. Headache 1999; 39: 625-632.
• 41 May A. et al. [Treatment and prophylaxis for cluster headaches and other trigeminal autonomic headaches. Revised recommendations of the German Migraine and Headache Society]. Schmerz 2005; 19: 225-241.
• 42 Melhado E. et al. Headaches during pregnancy in women with a prior history of menstrual headaches. Arq Neuropsiquiatr 2005; 63: 934-940.
• 43 Moore MP, Redman CW. Case-control study of severe pre-eclampsia of early onset. Br Med J (Clin Res Ed) 1983; 287: 580-583.
• 44 Newport DJ. et al. Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy. Am J Psychiatry 2005; 162: 2162-2170.
• 45 O’Quinn S. et al. Pregnancy and perinatal outcomes in migraineurs using sumatriptan: a prospective study. Arch Gynecol Obstet 1999; 263: 7-12.
• 46 Olesen C. et al. Pregnancy outcome following prescription for sumatriptan. Headache 2000; 40: 20-24.
• 47 Ortega D. et al. Excretion of lidocaine and bupivacaine in breast milk following epidural anesthesia for cesarean delivery. Acta Anaesthesiol Scand 1999; 43: 394-397.
• 48 Park-Wyllie L. et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000; 62: 385-392.
• 49 Peikert A. et al. Prophylaxis of migraine with oral magnesium: results from a prospective, multicenter, placebo-controlled and double-blind randomized study. Cephalalgia 1996; 16: 257-263.
• 50 Pfaffenrath V. et al. Magnesium in the prophylaxis of migraine--a double-blind placebo-controlled study. Cephalalgia 1996; 16: 436-440.
• 51 Pradat P. et al. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res A Clin Mol Teratol 2003; 67: 968-970.
• 52 Rasmussen BK. et al. Epidemiology of headache in a general population--a prevalence study. J Clin Epidemiol 1991; 44: 1147-1157.
• 53 Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992; 12: 221-228 discussion 186..
• 54 Raymond GV. Teratogen update: ergot and ergotamine. Teratology 1995; 51: 344-347.
• 55 Ross-Lee LM. et al. Aspirin pharmacokinetics in migraine. The effect of metoclopramide. Eur J Clin Pharmacol 1983; 24: 777-785.
• 56 Rotton WN, Sachtleben MR, Friedman EA. Migraine and eclampsia. Obstet Gynecol 1959; 14: 322-330.
• 57 Sances G. et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003; 23: 197-205.
• 58 Scharff L, Marcus DA, Turk DC. Headache during pregnancy and in the postpartum: a prospective study. Headache 1997; 37: 203-210.
• 59 Schulman EA, Dermott KF. Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs. Headache 2003; 43: 729-733.
• 60 Sheehan P. Hyperemesis gravidarum--assessment and management. Aust Fam Physician 2007; 36: 698-701.
• 61 Sheffield RE. Migraine prevalence: a literature review. Headache 1998; 38: 595-601.
• 62 Shuhaiber S. et al. Pregnancy outcome following first trimester exposure to sumatriptan. Neurology 1998; 51: 581-583.
• 63 Somerville BW. Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology 1975; 25: 239-244.
• 64 Somerville BW. Estrogen-withdrawal migraine. II. Attempted prophylaxis by continuous estradiol administration. Neurology 1975; 25: 245-250.
• 65 Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972; 22: 355-365.
• 66 Somerville BW. The role of progesterone in menstrual migraine. Neurology 1971; 21: 853-859.
• 67 Stein G. et al. Headaches after childbirth. Acta Neurol Scand 1984; 69: 74-79.
• 68 Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence. A review of population-based studies. Neurology 1994; 44: S17-23.
• 69 Stovner L. et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007; 27: 193-210.
• 70 van Vliet JA. et al. Cluster headache in women: relation with menstruation, use of oral contraceptives, pregnancy, and menopause. J Neurol Neurosurg Psychiatry 2006; 77: 690-692.
• 71 Wainscott G. et al. The outcome of pregnancy in women suffering from migraine. Postgrad Med J 1978; 54: 98-102.
• 72 Weber-Schoendorfer C. et al. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study. Reprod Toxicol 2008; 26: 24-30.
• 73 Wojnar-Horton RE. et al. Distribution and excretion of sumatriptan in human milk. Br J Clin Pharmacol 1996; 41: 217-221.
• 74 Wright GD, Patel MK. Focal migraine and pregnancy. Br Med J (Clin Res Ed) 1986; 293: 1557-1558.